Gene: UPP1
Official Full Name: uridine phosphorylase 1provided by HGNC
Gene Summary: This gene encodes a uridine phosphorylase, an enzyme that catalyzes the reversible phosphorylation of uridine (or 2'- deoxyuridine) to uracil and ribose-1-phosphate (or deoxyribose-1-phosphate). The encoded enzyme functions in the degradation and salvage of pyrimidine ribonucleosides. [provided by RefSeq, Oct 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05866 | UPP1 Knockout cell line (HeLa) | Human | UPP1 | 1:3~1:6 | Negative | Online Inquiry |
KO05867 | UPP1 Knockout cell line (HCT 116) | Human | UPP1 | 1:2~1:4 | Negative | Online Inquiry |
KO05868 | UPP1 Knockout cell line (HEK293) | Human | UPP1 | 1:3~1:6 | Negative | Online Inquiry |
KO05869 | UPP1 Knockout cell line (A549) | Human | UPP1 | 1:3~1:4 | Negative | Online Inquiry |
UPP1 Gene Knockout Cell Lines are specialized cellular models engineered to specifically disrupt the expression of the UPP1 gene, which encodes the enzyme uridine phosphorylase 1. This genetic modification enables researchers to study the functional role of UPP1 in various cellular processes and its implications in disease states. By utilizing CRISPR-Cas9 technology, these cell lines offer precise genome editing capabilities that allow for the targeted removal of UPP1, leading to a comprehensive assessment of metabolism, signaling pathways, and cellular responses.
The primary function of UPP1 is to convert uridine and phosphate into uracil and α-D-ribose-1-phosphate, thereby playing a critical role in nucleotide metabolism and pyrimidine salvage pathways. By knocking out UPP1, these cell lines facilitate investigations into altered metabolic states, potential cellular stress responses, and the impact of UPP1 on cancer cell proliferation and chemoresistance. Due to the relevance of UPP1 in several pathological conditions, including certain cancers and metabolic disorders, the utility of these knockout cell lines extends to both fundamental research and translational studies.
One of the key advantages of UPP1 Gene Knockout Cell Lines is their ability to provide a robust platform for screening compounds that may influence UPP1 pathways or its associated metabolites. Unlike traditional methods that often rely on pharmacological inhibition, these cell lines offer a genetically defined model that allows for more nuanced interpretation of experimental data. This specificity is crucial in yielding more accurate insights into UPP1’s biological functions as well as its potential as a therapeutic target.
Researchers and clinicians will find significant value in employing these knockout models for drug discovery, metabolic profiling, and mechanistic studies, thereby contributing to advancements in personalized medicine and targeted therapies. Moreover, our commitment to scientific rigor and innovation ensures that our UPP1 Gene Knockout Cell Lines are produced under stringent quality controls, backed by extensive characterization to meet the evolving demands of the research community. As experts in the field of biological products, we are dedicated to providing tools that empower scientists to unlock new biological insights and drive impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.